Investigate Risperidone for the Treatment of Schizophrenia in Adolescents

NCT00088075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.